Screening for chronic hepatitis B infection in New Zealand: Unfinished business

New Zealand Medical Journal

Volumn 118, Issue 1211, 2005, Pages

  Gane, Edward ^a  

^a New Zealand Liver Transplant Unit   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; RECOMBINANT VACCINE;

CANCER SCREENING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG SAFETY; EARLY DIAGNOSIS; EDITORIAL; FOLLOW UP; HEALTH CARE COST; HEALTH PROMOTION; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; INFECTION RISK; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; LONG TERM CARE; MORBIDITY; MORTALITY; NEW ZEALAND; PREVALENCE; PRIMARY MEDICAL CARE; PROGNOSIS; PROTEIN BLOOD LEVEL; RELIABILITY; RESOURCE ALLOCATION; SAFETY; SCREENING TEST; VACCINATION; VIRUS CARRIER; ABORIGINE; ASIAN; BLOOD; ETHNOLOGY; FEMALE; MALE; MASS SCREENING; NOTE; PATIENT SELECTION;

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; MASS SCREENING; NEW ZEALAND; OCEANIC ANCESTRY GROUP; PATIENT SELECTION; PREVALENCE;

EID: 21244503592     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Editorial

References (24)

1. Chang M, Chen C, Lai M, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children.N Engl J Med 1997; 336: 1855-9.
2. Screening and HBV infection in New Zealand. Report to the Director-General of Health of the Working Party on Hepatitis B; 1994
3. Feasibility of screening for any surveillance of Hepatitis B in a single geographic area. Report to the Director-General of Health of the Working Party on Hepatitis B; September 1996.
4. Blakely T, Thornley C. Screening for hepatitis B carriers: evidence, and policy development in New Zealand. N Z Med J.1999;112:431-3.
5. Gane E. Impact of hepatitis B infection in south Auckland. N Z Med J. 1998;1063:120-2.
6. Christie P. Primary hepatocellular carcinoma: early diagnosis and importance of screening. N Z Med J. 1995;108:175-6.
7. Lee SP, Lane MR, Yeong ML, Maher K. A clinical-pathological study on chronic hepatitis in Auckland. N Z Med J. 1984;97:515-7.
8. Weir R, Brunton C, Blakely T. Chronic liver disease mortality attributable to hepatitis B and C in New Zealand. J Gastro Hepatol. 2002;17:582-8.
9. Gane E, McCall J, Streat S, et al. Liver transplantation in New Zealand: the first four years. N Z Med J. 2002;115(1159). URL: http://www.nzma.org.nz/journal/115-1159/120
10. Fung J, Gane E, Hornell J, et al. Improved survival with screening for hepatocellular carcinoma in chronic hepatitis B: preliminary results of a national surveillance programme. Hepatology. 2004;40:258A.
11. Wilson JHG, Junguer G. The Principles and Practice of Screening for Disease. Public Health Papers 34. Geneva: WHO; 1968.
12. Prorok P. Epidemiologic approach for cancer screening. Am J Paediatr Haematol Oncol. 1992;14:117-28.
13. Blakely T, Salmond C, Tobias M. Hepatitis B virus carrier prevalence in New Zealand: population estimates using the 1987 police and customs personnel survey. N Z Med J. 1998;111:142-4.
14. Milne A, Allwood G, Moyes C, et al. Prevalence of hepatitis B infections in a multiracial New Zealand community. N Z Med J. 1985;98:529-32.
15. National Maori, Pacific and Asian Population Projections (2001(base) - 2021). Available online. URL: http://www.stats.govt.nz/analytical-reports/dem-trends-03/ dem-trends-2003-part-8-nat-demo-projections.htm Accessed March 2005.
16. Lai C, Chien R, Leung N, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med. 1998;339:61-8.
17. Liaw Y, Sung J, Chow W, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521-31.
18. Dienstag J, Goldin R, Heathcote E, et al. Histological outcome during long-term lamivudine therapy. Gastroenterology. 2003;124:105-17.
19. McMahon B, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaskan natives infected with chronic hepatitis B: a 16 year population-based study. Hepatology. 2000;32:842-6.
20. Zhang B-H, Yang B-H, Tang Z-Y. Randomised controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol. 2004;130:417-22.
21. Sangiovanni A, Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterol. 2004;126:1005-14.
22. Sarasin F, Gistra E, Hadengue A. Cost-effectiveness of screening for detection of small hepatocellular carcinoma. Am J Med. 1996;171:422-34.
23. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology. 1998;27:273-8.
24. Bandaranayake D, Salmond C, Tobias M. Occupational risk of hepatitis B for police and customs personnel. Am J Epidem. 1991;134:1447-53.